Tay Therapeutics

Dundee, United Kingdom

Tay Therapeutics is a drug discovery company that develops the next generation of topical and oral therapies for inflammatory conditions.

$2.2M raised

Nov 2021

Seed

Biopharma Biotechnology Health Care Health Diagnostics

Top Investors

Scottish Enterprise University of Dundee O2h Ventures Wren Capital Meltwind Advisory

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tay Therapeutics

How much funding has Tay Therapeutics raised?

Tay Therapeutics has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in November 2021.

Who are Tay Therapeutics's investors?

Tay Therapeutics's investors include Scottish Enterprise, University of Dundee, O2h Ventures, Wren Capital, Meltwind Advisory.

Where is Tay Therapeutics headquartered?

Tay Therapeutics is headquartered in Dundee, United Kingdom.

What does Tay Therapeutics do?

Tay Therapeutics is a drug discovery company that develops the next generation of topical and oral therapies for inflammatory conditions.

What stage is Tay Therapeutics at?

Tay Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 2, 2021.

MLA

"Tay Therapeutics — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/tay-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2021). Tay Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/tay-therapeutics

Wikipedia (cite web)

{{cite web |title=Tay Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tay-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 2, 2021.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.